Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
J
Justin de Brabander
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
8.1K
Citations
22
h-index
35
i10-index
Justin de Brabander is an academic researcher from Amsterdam UMC Location University of Amsterdam. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Long-Term Effects of COVID-19. The author has an h-index of 22, co-authored 57 publications.
ORCID: 0000-0002-3596-5086Papers by this author
worksInborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Mapping the human genetic architecture of COVID-19
2021 · Nature · 1,104 citations
https://doi.org/10.1038/s41586-021-03767-x
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
2023 · Genome Medicine · 77 citations
https://doi.org/10.1186/s13073-023-01173-8
Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome
2022 · American Journal of Respiratory and Critical Care Medicine · 62 citations
https://doi.org/10.1164/rccm.202202-0274oc
The host response in different aetiologies of community-acquired pneumonia
2022 · EBioMedicine · 37 citations
https://doi.org/10.1016/j.ebiom.2022.104082
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat